Not finding it? Sign in to also search OpenAlex live.
-
98 Long-lasting efficacy following guselkumab induction therapy in mild psoriasis patients, results from a randomized, placebo-controlled exploratory clinical trial2023 Journal of Investigative Dermatology article Immunology and Microbiology Psoriasis: Treatment and Pathogenesis Open access
Jannik Rousel, M. Bergmans, L. van der Meulen, Lisa Pagan, D. de Bruin, M. de Kam, +7 more
0citations -
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study2024 United European Gastroenterology Journal article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Edouard J. Louis, Tadakazu Hisamatsu, Toshifumi Hibi∥, Louis Dron, +5 more
9citations -
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial2020 The Lancet article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Philip J. Mease, Proton Rahman, Alice Bendix Gottlieb, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie Lillian Xu, +5 more
359citations -
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis2023 Seminars in Arthritis and Rheumatism article Medicine Rheumatoid Arthritis Research and Therapies Open access
Lotte van Ouwerkerk, Sytske Anne Bergstra, Tjardo Daniël Maarseveen, Tom W. J. Huizinga, Rachel Knevel, Cornelia F Allaart
4citations -
Remission Definitions Guiding Immunosuppressive Therapy in Rheumatoid Arthritis: Which is Best Fitted for the Purpose?2023 SSRN Electronic Journal preprint Medicine Rheumatoid Arthritis Research and Therapies Open access
Cátia C. M. Duarte, Ricardo J O Ferreira, Paco M J Welsing, Johannes W. J. Jacobs, Laure Gossec, Pedro Machado, +2 more
0citations -
OP0189 REMISSION CRITERIA GUIDING IMMUNOSUPPRESSIVE THERAPY IN RA: WHICH IS BEST FITTED FOR THIS PURPOSE?2023 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Cátia C. M. Duarte, Ricardo J O Ferreira, Paco M J Welsing, J. W. G. Jacobs, Laure Gossec, Pedro Machado, +2 more
0citations -
Outcome of adult patients with JIA treated with the biosimilar Benepali®: results of the biologic register JuMBO2022 Arthritis Research & Therapy article Immunology and Microbiology Biosimilars and Bioanalytical Methods Open access
Kristina Vollbach, Klaus Tenbrock, Gerd Horneff, Ariane Klein, Ivan Foeldvari, Johannes‐Peter Haas, +8 more
5citations -
POS0918 EVALUATION OF SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING IXEKIZUMAB THERAPY OVER 2 YEARS2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Mikkel Østergaard, J. D. Reveille, Xenofon Baraliakos, Andris Kronbergs, David M. Sandoval, +4 more
2citations -
AB0403 INFLUENCE OF BODY WEIGHT, SEX AND PRIOR BIOLOGIC HISTORY ON TREATMENT OUTCOMES ASSOCIATED WITH TAK-279, A HIGHLY SELECTIVE ORAL TYROSINE KINASE 2 (TYK2) INHIBITOR, IN A PHASE 2B RANDOMIZED TRIAL IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2024 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments
L. Eder, Elena Tomaselli Muensterman, Désirée van der Heijde, A. Kivitz, Muhammad Rehman, J. Chen, +1 more
1citations -
OP0221 THERAPY WITH JAK INHIBITORS AND THE RISK OF CARDIOVASCULAR EVENTS IN A DUTCH RHEUMATOID ARTHRITIS POPULATION2023 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Călin D. Popa, M. Opdam, Nathan den Broeder, Maike H M Wientjes, Alfons A den Broeder
0citations -
POS0440 REDUCTION IN MONOCYTE COUNT PREDICTS SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF THERAPY2021 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Raj Amarnani, Muhammed Mainuddin, Muhammad Ruhul Amin Shipa, Su‐Ann Yeoh, Michael R. Ehrenstein
0citations -
FRI0139 FILGOTINIB PROVIDED RAPID AND SUSTAINED RELIEF OF PAIN AND FATIGUE AND IMPROVED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DMARDS: RESULTS FROM THE FINCH 2 STUDY2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
David Walker, Tsutomu Takeuchi, Beatrix Bartók, I. H. Lee, Robin Besuyen, J.E. Gottenberg, +1 more
0citations -
Gene therapy strategies for RAG1 deficiency: Challenges and breakthroughs2024 Immunology Letters article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access
Giorgio Gilioli, Arjan C. Lankester, Sander de Kivit, Frank J. T. Staal, Lisa M. Ott de Bruin
8citations -
Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 12 Months of Maintenance Therapy
Jonathan L. Kaufman, Jacob P. Laubach, Douglas Weston Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, +21 more
24citations -
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial2023 Journal of the American Academy of Dermatology article Immunology and Microbiology Psoriasis: Treatment and Pathogenesis Open access
Jannik Rousel, M. Bergmans, Laura W.J. van der Meulen, Lisa Pagan, Digna T. de Bruin, Marieke L. de Kam, +7 more
6citations -
Abstract PD6-11: PD6-11 Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program
Danielle Brandes Zakon, Coralie Poncet, Fátima Cardoso, Neven Anouk, Vicente Valero, Stefan Paul Aebi, +28 more
0citations -
Post-Transplant HCC Recurrence and Survival: Impact of Bridging Therapy and Tumor Biology in 185 Consecutive Liver Transplants2026 Journal of Clinical Medicine article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Bengt Arne Wiemann, Clara Antonia Weigle, Julian Palzer, Philipp Tessmer, Oliver Beetz, Dennis Kleine-Döpke, +5 more
0citations -
Transformed FL shows improved survival after CAR T-cell therapy compared to de novo LBCL, but early transformation (<12 months) defines a poor-risk subgroup: Results from a nationwide cohort
Hilde Van Der Galien, Pim G. N. J. Mutsaers, Margot Jak, Marjolein van der Poel, Marije T. Nijk, Kees Meijer, +13 more
0citations -
BEAM COMMISSIONING AND EXPERIMENTAL VALIDATION OF A MC DOSE ENGINE FOR PLAN QA IN BRAGG-PEAK UHDR/FLASH PROTON THERAPY2026 International Journal of Particle Therapy article Medicine Radiation Therapy and Dosimetry Open access
Ylva Bornhauser, Anne Zur Horst, Thijs Van Staveren, Nils Krah, Steven JM Habraken, Mischa S. Hoogeman
0citations